About FDA
Percentage of manufacturing supplements (CBE and CBE-30 day Supplements) with action due dates occurring during the month that were reviewed and acted upon within 6 months of receipt (PDUFA) (1)
Dictionary: Licensed manufacturers must submit a Changes Being Effected (CBE) or CBE-30 supplement to FDA for any change to a product that has a moderate potential to have an adverse effect on identity, strength, quality, purity or potency of the product as they may relate to the safety or effectiveness of the product. Examples of such changes include production process, quality controls, equipment, facilities, or responsible personnel. Distribution of product made with the change may commence 30 days after FDA receipt of a CBE-30 supplement, or immediately upon FDA receipt of a CBE supplement. This measure will allow OCBQ to monitor its performance in issuing decisions for manufacturing supplements (CBE) within established timeframes.
Information is current as of September 30, 2012
Fiscal Year - 2012

Time | Target | Percent |
---|---|---|
Oct 2011 | 90 | 100 |
Nov 2011 | 90 | 100 |
Dec 2011 | 90 | 100 |
Jan 2012 | 90 | 100 |
Feb 2012 | 90 | 100 |
Mar 2012 | 90 | 100 |
Apr 2012 | 90 | 100 |
May 2012 | 90 | 100 |
Jun 2012 | 90 | 100 |
Jul 2012 | 90 | 60 |
Aug 2012 | 90 | 100 |
Sep 2012 | 90 | 100 |
FY 2012 Overall: 99%
Footnotes
- (1) The monthly percentages are based on a denominator that excludes supplements that were withdrawn by the manufacturers prior to the due date.
Total number of manufacturing supplements (CBE and CBE-30 day Supplements) with action due dates occurring during the month that were reviewed and acted upon within 6 months of receipt (PDUFA)
Fiscal Year - 2012

Time | Target | Number |
---|---|---|
Oct 2011 | N/A | 16 |
Nov 2011 | N/A | 21 |
Dec 2011 | N/A | 53 |
Jan 2012 | N/A | 12 |
Feb 2012 | N/A | 17 |
Mar 2012 | N/A | 21 |
Apr 2012 | N/A | 14 |
May 2012 | N/A | 10 |
Jun 2012 | N/A | 27 |
Jul 2012 | N/A | 3 |
Aug 2012 | N/A | 9 |
Sep 2012 | N/A | 8 |
FY 2012 Total: 211
Total number of manufacturing supplements (CBE and CBE-30 day Supplements) with action due dates occurring during the month
Fiscal Year - 2012

Time | Target | Number |
---|---|---|
Oct 2011 | N/A | 16 |
Nov 2011 | N/A | 21 |
Dec 2011 | N/A | 53 |
Jan 2012 | N/A | 12 |
Feb 2012 | N/A | 17 |
Mar 2012 | N/A | 21 |
Apr 2012 | N/A | 14 |
May 2012 | N/A | 10 |
Jun 2012 | N/A | 27 |
Jul 2012 | N/A | 5 |
Aug 2012 | N/A | 9 |
Sep 2012 | N/A | 8 |
FY 2012 Total: 213
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.